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Background: Despite the clinical significance of Salmonella infections, surveillance data worldwide remains limited
and is more so exemplified by the lack of reports from Africa especially in eastern, central and western Africa. This
study reports on Salmonella serotypes as significant causes of blood stream infections (BSI) and multidrug antibiotic
resistance at Korle-Bu Teaching Hospital in Accra, Ghana.
Methods: Antibiogram patterns, seasonal variations in disease incidence and predisposing factors for infection with
Salmonella serotypes were analyzed retrospectively over a 4-year period from January 2010 to December 2013.
Blood cultures were processed with BACTEC 9240 blood culture system. Speciation was done with BBL Crystal
Enteric/Nonfermenter identification system®, and with slide agglutination using specific antisera. Antimicrobial
susceptibility testing was carried out by the Kirby-Bauer disc diffusion method according to Clinical and Laboratory
Standard Institute guidelines.
Results: We report a 6.5% (n = 181/2768) prevalence of Salmonella bacteraemia at the Korle-Bu Teaching Hospital;
with a preponderance of non-typhoidal salmonellae (NTS) over typhoidal salmonella (TS) (n = 115/181, 63.5% versus
n = 66/181, 36.5%; P-value <0.002). Children under 5 years bore the brunt of the disease (n = 93/174, 53.4%). Resistance
to ciprofloxacin (n = 1/127, 0.7%), amikacin (n = 3/81, 3.7%), and cefotaxime (n = 6/99, 6.1%) remained low, despite high
levels of multidrug resistant Salmonella phenotypes (n = 81/181, 44.2%). In multivariate analysis, and among patients
with Salmonella BSI, those < 1 year old had reduced risk of non-typhoidal infections [Odds ratio, 0.51; 95% confidence
interval (95% CI), 0.16-0.92, P-value 0.021]. Similarly, patients with cefuroxime resistant strans were at increased risk of
having multidrug resistant Salmonella BSI (OR, 8.97; 95% CI, 3.62-24.15; P-value, 0.001).
Conclusions: Salmonellae, predominantly NTS, account for a reasonable low proportion of positive blood cultures in
our tertiary care setting; but with significant multidrug resistant phenotypes and low ciprofloxacin and cefotaxime
resistance.
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Invasive salmonellosis remains a global public health
problem. Global estimates in 2000 showed that typhoid
fever accounted for 21, 000 000 illnesses and 216, 000
deaths, whilst 5, 412 744 illnesses were attributable to
paratyphoid fever [1]. The epidemiology of invasive sal-
monellosis varies worldwide. In Europe, non-typhoidal
Salmonella (NTS) mainly Salmonella Enteritidis predom-
inate but are rarely associated with systemic disease other
than diarrhoea except for severely immunocompromised* Correspondence: successfulnoahforchrist@yahoo.com
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unless otherwise stated.patients) [2]. In South East Asia, the predominant organ-
ism is Salmonella Typhi [1,3], whilst in Africa NTS pre-
dominates [1,4-8]. The disease is common in developing
countries and concomitant with poor public health and
low socio economic indices [9,3]. Thus the bulk of the dis-
ease burden is seen in South East Asia, Africa and Latin
America [3]. Its’ epidemiology is also affected by seasonal
variations [2,10]. In India peak incidence of Salmonella
Typhi occurs between April-June (dry season) followed by
July-September (monsoon season). In Africa the epidemi-
ology of invasive salmonellosis has been linked with malaria
infections [4,8,11,12].is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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invasive salmonellosis with a few studies suggesting high
disease burden in children. A recent report found invasive
non-typhoidal salmonellosis in 10% of hospitalized chil-
dren [5], whilst another study documented a prevalence of
57% in infant bactereamia [4].
Salmonella species are increasingly evolving antimicro-
bial resistance to several commonly used antimicrobial
agents. This phenomenon which started with a report of
chloramphenicol resistant Salmonella Typhi from India in
1972 [13] has increased to the extent that multi-drug re-
sistant strains are now circulating globally [14]. This is the
result of indiscriminate use of antibiotics in areas of high
transmission or endemicity [14]. The problem of MDR
Salmonella increases the challenge in the management of
the disease in endemic regions by increasing morbidity
and mortality as well as cost of treatment.
Surveillance data worldwide remains limited (2), and is
more so exemplified by the lack of data from Africa espe-
cially in eastern, central and western Africa (1). Such data
is relevant in decision making by public health officials for
disease prevention and control programmes (1). In Ghana
the situation is no different. In this study, we have docu-
mented the epidemiology of invasive salmonellosis in a
tertiary hospital setting in Ghana. Our primary outcomes
were to report the prevalence, circulating serotypes, anti-
microbial resistance patterns, seasonal variations in




The retrospective study was conducted in Korle-Bu Teach-
ing Hospital (KBTH), a 2000-bed tertiary teaching hospital
with about 200 admissions per day [15]. The hospital
covers all medical specialties and provides referral health-
care services to an estimated population of 24 million
Ghanaians. The central outpatient department records
about 29,757 patient turnout per month [15]. The bacteri-
ology unit of the Microbiology Department of KBTH pro-
cesses over 40,000 clinical cultures annually.
Study design
From January 2010 through December 2013, we studied
all clinical bloodstream isolates of salmonellae collected at
the bacteriology unit of the Central Microbiology Labora-
tory in KBTH. Two sampling approaches were used. First,
all Salmonella isolates recovered from blood cultures of
patients visiting the microbiology laboratory of KBTH
were characterized and analysed. Second, we reviewed
laboratory records of all patients with Salmonella BSI for
microbiological data. Salmonella species were selected
based on the following criteria: (i) confirmed as the causa-
tive agent of the infection for which blood cultures wereperformed, and (ii) identified as first isolate per patient
within study period. Multiple isolates per patient were con-
sidered only if antibiogram was different than previous,
and their bacteraemia episodes were more than 3 months
separate.
Patients’ record review
To provide accurate information, patients and isolates
data were abstracted in the following two steps, (i) manual
work through of laboratory records, and (ii) physician-
assisted medical reconciliation of data. Data were retro-
spectively reviewed and compared. When bacteraemic
episodes with Salmonella were identified, we categorized
those with typhoid and non-typhoid isolates. Data were
retrospectively reviewed and compared. Subsequently,
univariate and multivariate analysis were conducted to
compare patients with Salmonella BSI caused by typhoidal
strains to their counterparts with non-typhodal isolates
using patients’ data from laboratory records as independ-
ent predictor variables. Similar analysis were also con-
ducted to compare a second case group comprising
patients with BSI caused by MDR Salmonella to those
with non-MDR Salmonella BSI. Each patient was included
only once for each outcome. Patients’ groups were com-
pared regarding the following: demographics (age, gender),
sickle cell disease, month and year of infection as well as
patients’ hospital and assigned department of care. We also
collected data on variables related to infections: types of
Salmonella species and antibiogram.
Specimen, culture and identification
During the study period, and as part of hospital routing
care, 23,708 patients submitted blood cultures for bacterio-
logical investigations. Speceimens were processed with
BACTEC 9240 blood culture system (Becton Dickinson,
NJ, USA) according to manufacturer’s instructions. A total
of 2,768 blood cultures were positive for various infec-
tions. Subcultures were made on blood, chocolate and
MacConkey agar; and were incubated aerobically at 37°C
for 20 hours. Typical lactose non-fermenting colonies
were speciated with standard bacteriologic reactions and
BBL Crystal Enteric/Nonfermenter identification system®
(Becton Dickinson, NJ, USA). Salmonellae were confirmed
with slide agglutination using specific antisera (Himedia
Laboratories, India).
Susceptibility testing
The susceptibilities of isolates to the antimicrobial agents
ampicillin (10 μg), cefuroxime (30 μg), cefotaxime (30 μg),
chloramphenicol, (30 μg), cotrimoxazole (25 μg), gentami-
cin (30 μg), amikacin (30 μg), ciprofloxacin (5 μg), and
levofloxacin (5 μg) (HiMedia Laboratories, India) were
determined with Kirby-Bauer disc diffusion method in
accordance with the Clinical and Laboratory Standards
Labi et al. BMC Infectious Diseases  (2014) 14:3857 Page 3 of 10Institute (CLSI) guidelines [16]. The reference strain E.
coli ATCC 25922 was included as quality control in the
susceptibility assays. According to the international stand-
ard definitions for acquired resistance, and relative to the
panel of antibiotics tested, multidrug resistant (MDR)
phenotype was defined as in vitro non-susceptibility to ≥1
agent in ≥3 antimicrobial categories [17]: penicillins, cepha-
losporins, beta-lactamase inhibitor combinations, fluoroqui-
nolones, aminoglycosides, chloramphenicol, folate pathway
inhibitors, tetracyclines, macrolides and glycopeptides.
Statistics
Data from laboratory investigations were captured into
Microsoft ACCESS to generate a database, and exported
into Statistical Package for Social Sciences (SPSS, Version
20.0) for data editing and statistical analyses. Continuous
data were compared using student’s t-test, analyses of vari-
ance (ANOVA) or Mann–Whitney U test, (respectively for
normalized and non-parametric distributions), with point
estimates of statistical significance indicated by with 2
tailed P-values <0.05. Categorical data were compared
across study parameters using Chi-square with Maracuilo’s
post hoc tests for multiple comparisons, or the Fisher’s
exact test. Correlations were assessed with Pearson co-
efficient (r) or Spearman’s rho (rs) or their coefficient of
determination (r2 or rs
2) where appropriate. Univariate
comparisons were computed with Chi-square tests and un-
adjusted Odds ratios (OR) at 95% confidence interval (CI).
From univariate analyses, variable with a P-value <0.05
were analysed in a multivariate logistic regression models
to identify independent risk factors. Predictive accuracy of
the models was evaluated by Hosmer and Lemeshow
goodness-of-fit test with P-value >0.05 suggesting that the
model predicts accurately on average. The area under the
ROC (Receiver Operating Characteristic) Curve > 0.7 was
used to analyse the discriminatory capability of bacterea-
mia with typhoidal salmonella or MDR salmonellae versus
their respective controls.
Ethical considerations
Ethical approval was not required as the study was regarded
as part of routine surveillance measures for infection
control by the Ethical and Protocol Review Committee of
University of Ghana Medical School, College of Health
Sciences. Considering the retrospective nature of the study,
we could not obtain patients consent for use of clinical data.
Nevertheless, on receipt of isolates and patients’ data, we
de-identified all patients to ensure anonymity. We also allot-
ted arbitrary numbers to all isolates assigned to the study.
Results
Pravalence of salmonellae
During the study period, 23,708 blood cultures were sub-
mitted for bacteriological investigations. A total of 2,768blood cultures were positive for various infections. From
these, 181 (6.5%) non-duplicate salmonellae were recov-
ered in 2010 (n = 37/749, 4.9%), 2011 (n = 53/701, 7.5%),
2012 (n = 63/796, 7.9%), and 2013 (n = 28/432, 6.5%). Thus
181 patients were included in this study (98 males and 83
females), with a mean age of 9.5 years (interquartile range,
6 years). The prevalence of TS and NTS were respectively
2.4% [n = 66/2768; 95% confidence interval (CI), 1.93-3.13]
and 4.10% (n = 115/2768; 95% CI, 3.10-4.51); with the total
number of TS being significantly lower than that of NTS
(n = 66/181, 36.5% versus 115/181, 63.5%; P-value <0.002).
Overall, we did not observe correlation between salmonel-
lae prevalence and study years [rs(2) = 0.4, P-value = 0.617].
Table 1 shows the distribution of Salmonella species across
study years. Salmonella Enteritidis (n = 93/181, 51.1%), and
S. Typhi (n = 48/181, 26.5%) were the predominant sero-
type. Others were S. Typhumurium (n = 22/181, 11.5%)
and S. Paratyphi (n = 18/181, 9.9%). Marascuilo’s post hoc
test was conducted to compare the proportions of salmon-
ellae recovered across the 4 study years. Over the study
period the yearly populations of each salmonella serotype
had similar proportion of defects except for S. Enteritidis
for which more isolates were recovered in 2013 compared
to 2010 (P-value = 0.018), and in 2011 compared to 2013
(P-value = 0.019).
Cefuroxime resistant phenotypes
As a crude measure to determine beta-lactamase produ-
cing phenotypes, we examined the resistance pattern of the
salmonellae to cefuroxime (30 μg) (Table 1). The 4-year
prevalence of cefuroxime resistance was similar among TS
and NTS (n = 11/66, 16.7% versus n = 21/115, 18.2%
respectively; P-value = 0.786). Marascuilo’s comparisons
showed homogeneity in the proportion of cefuroxime
resistant strains across the four yearly populations of
typhoidal salmonellae (P-value = 0.1115). Conversely,
although we recorded significant difference (P-value =
0.0161) in the proportion of cefuroxime resistance for the
yearly populations of non-typhoidal salmonellae, no differ-
ence between any two particular years was significant
(marascuilo’s post hoc > 0.05 for all pairwise comparisons).
For TS and NTS, the Spearman’s ranked test showed no
correlations between cefuroxime prevalence and study
years [TS, rs(2) = −0.6, P-value = 0.438; NTS, rs(2) = −0.8;
P-value = 0.231].
Seasonal variations in prevalence of salmonellae
Figure 1 shows the monthly distribution of TS and NTS
over a four-year study period. There was seasonality for
TS, but not NTS, with rainfall pattern. The peak seasons
for TS bactereamia were observed in March though July
and from September through November; and coincided
with the two rainy seasons in Ghana — April to July, and
September to November (Figure 1). For instance, the
Table 1 A four- year distribution of salmonellae recovered from blood cultures submitted to microbiology laboratory
of Korle-Bu Teaching Hospital
Isolates Number of Salmonella speciesa (%)
Total
(n = 181)












66 (36.5)a 11 (16.7)a 14 (37.8) 4 (28.5) 12 (22.4) 4 (30.7) 27 (44.8) 2 (7.4) 13 (22.4) 1 (7.6) 0.1322
S. Typhi 48 (26.54) 7 (14.5) 8 (21.6) 2 (25.0) 7 (14.8) 2 (25.0) 25 (61.9) 2 (3.3) 8 (28.5) 1 (12.5) 0.8056
S. Paratyphi A 12 (6.6) 4 (33.3) 3 (8.1) 2 (66.6) 3 (5.5) 2 (66.7) 1 (1.6) 0 5 (17.8) 0 0.0441
S. Paratyphi B 6 (3.3) 0 3 (8.1) 0 2 (3.7) 0 1 (1.6) 0 0 0 0.1988
Non-typhoidal
Salmonella
115 (63.5)b 21 (18.2)a 23 (62.1) 5 (21.7) 41 (77.3) 11 (23.4) 36 (57.1) 4 (11.1) 15 (53.5) 1 (6.7) 0.1322





S. Typhumurium 22 (12.2) 3 (13.6) 7 (18.9) 1 (14.2) 8 (14.0) 2 (25.0) 7 (6.1) 0 0 0 -
aCrx res, cefuroxime resistant; bP-value determined with Marascuilo’s comparisons post hoc tests for multiple proportions;
cP, P-value for significant pairwise
comparisons between study years;
*Differing subscripts within a column indicate significant difference at P-value < 0.05; SpearmansRanked Correlation between prevalence of Salmonella isolates
and study years, rs(2) = +0.4; P-value = 0.617.
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(2.2%) and May (2.0%) for 2010; and in May (2.3%) for
2011. April (2.2%), May (2.75%) and August (2.2%) re-
corded the highest bactereamic episodes in 2012; whereas
Sepetember (1.6%) and November (1.6%) accounted for
the highest prevalence in 2013. Altogether, non-typhoidal
salmonellae (NTS) appeared to be more fairly distributed
across the months and over the years. For the particular
years under study, we sought to examine the correlation
between months and the number of salmonellae isolated.
The number of TS recovered in 2013, unllike the other
years, showed some significant degree of covariation with
months; and the direction of covariation was positive.
More so, 51.9% of the variance in the number of TS was
coupled with advancing months (rs = 0.799; rs
2 = 0.519;
P-value = 0.001). On the contrary, no significant trend in
correlation was observed between the number of non-
typhoidal Salmonella (NTS) and months of isolation for
any particular year.
Antibiotic susceptibility results
The in vitro susceptibility results of salmonellae to po-
tentially useful antimicrobial agents are shown in Table 2.
Overall, ampicillin, chloramphenicol and tetracycline
were the least effective antibiotics with over 70% of TS
and NTS resistant to each antimicrobial. For TS, no re-
sistance was found to cefotaxime and the ciprofloxacin;
whereas gentamicin, amoxicillin/clavulanate and amika-
cin were respectively ineffective against 4.1% (n = 1/24),
8.3% (n = 1/12) and 9.1% (n = 1/11) of the isolates. Simi-
larly, NTS were mostly susceptible to the ciprofloxacin(n = 134/135, 99.2%), amikacin (n = 70/71, 98.6%), cefo-
taxime (n = 93/99, 93.9%), and gentamicin (n = 84/93,
90.3%). The percentage resistance between TS and NTS
were similar for all tested antibiotics except cotrimoxa-
zole — with a smaller percentage of TS than NTS being
resistant to this antimicrobial (TS, 15.5%, n = 27/174 versus
NTS, 62.1%, n = 54/87; P-value = 0.002). Chloramphenicol
was the only antibiotic to which salmonellae resistance
appears to be increasing; we noted a positive correlation
between time over 4 years and percentage of NTS resistant
to this antimicrobial (rs = +1, P-value = 0.0001).
Multidrug resistance salmonellae
Eighty-one (44.8%) salmonellae expressed multidrug resist-
ant phenotypes. The multidrug resistant strains (MDRs)
were significantly more in NTS (n = 59/115, 51.3%) com-
pared to TS (n = 22/66, 33.3%); with cefuroxime resistant
phenotypes more abundant in TS (n = 9/22, 40.9%) than in
NTS (n = 18/59, 30.5%). Some MDRs (TS, n = 4/22, 18.2%;
NTS, n = 11/59, 18.6%) remained resistant to all except
one class of the antimicrobials tested. These were suscep-
tible to gentamicin (TS, n = 3/4, 75%; NTS, n = 9/11,
81.8%), amikacin (TS, n = 4/4, 100%; NTS, n = 11/11,
100%), the ciprofloxacin (TS, n = 4/4, 100%; NTS, n = 6/6,
100%), and cefotaxime (TS, n = 4/4, 100%; n = 6/11, 54.5%).
Age distribution of salmonellae strains
In Figure 2, we examined the age-specific incidence of TS
and NTS across study patients using locally weighted scat-
ter plot smoothing (LOWESS) fit lines. Two observations
are noteworthy. First, the results show similarities in the
Figure 1 Seasonal shifts in bactereamia infections caused by typhoidal (TS) and non-typhoidal Salmonella (NTS) from 2010 through
2013. Monthly variations (X-axis) in Salmonella infections for each year are reported as percentage prevalence (Y-axis); prevalence for TS and NTS
infections are respectively shown with dotted and plain lines. We observed a seasonal trend for TS, but not NTS, with rainfall pattern. The peak
seasons for TS bactereamia were observed in March though July and from September through November; and coincided with the two rainy
seasons in Ghana — April to July, and September to November.
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rence of Salmonella bacteraemia show contrasting pat-
terns for patients at extremes of ages. Specifically, TS and
NTS bactereamias increased with age and were highest in
children below 5 years, but declined gradually over ages 5
through 32, remaining fairly constant among the over 33
to 72-year-olds. A Pearson Product–moment Correlation
was run to determine the relationship between incidence
of Salmonella bactereamia and age. Whereas a negative
correlation was observed between incidence of TS and
age, only 21.5% of the incidence variance was accounted
for by increases in patients’ age (r = −0.464; r2 = 0.2153;
P-value = 0.0297). In contrast, no demonstrable measure
of covariation was recorded between NTS and age
(r = −0.1795; r2 = 0.0322; P-value = 0.2613). Overall, the
highest number of culture positive cases for TS and NTS
was observed in children 1 year of age (TS, n = 7/66,10.6%; NTS, n = 20/115, 17.4%), and the least from
amongst adults >33 years.
Predictors of Salmonella bactareamia
In Table 3, patients with typhoidal bactreamia were
matched to those with non-typhoidal bactreamia to iden-
tify variables that increase the likelihood of developing TS
BSI. Similar analysis were performed to determine factors
associated with increased risk of Salmonella BSI by MDR
salmonellae. Notable findings from univariate compari-
sons were that patients with typhoidal salmonellae were
less likely to be children under 1 year old [Odds ratio
(OR), 0.39; 95% confidence interval (CI), 0.18-0.84;
P-value, 0.014]; and were less often infected with MDR
strains (OR, 0.47; 95% CI, 0.25-0.89; P-value, 0.001). The
MDR salmonellae were more frequently cefuroxime resist-
ant (OR, 8.35; 95% CI, 3.02-23.05; P-value, 0.001). Patients
Table 2 Antibiotic susceptibility patterns of typhoidal and non-typhoidal salmonellea recovered from blood cultures
Antibiotics Proportion of resistant Salmonella species (%)
Total P-value 2010 2011 2012 2013 Correlation coefficientc,d
TSa NTSb TS NTS TS NTS TS NTS TS NTS TS NTS








Cefotaxime 0 6/99 (6.1) - 0 1/23 (4.5) 0 3/41 (7.3) 0 2/35 (57.1) 0 0 - rs = −0.2,
P = 0.8
Amoxicillin/ Clavulante 1/12 (8.3) 11/20 (55.5) <0.01 NT 2/5 (40.0) NT 6/7 (85.7) 1/12 (8.3) 3/8 (37.5) 0 0 - rs = −0.8,
P = 0.2








Chloramphenicol 27/44 (61.4) 66/90 (73.3) 0.1579 10/13 (76.9) 10/19 (52.6) 12/13 (92.3) 25/33 (75.7) 5/18 (27.7) 22/27 (81.5) NT 9/11 (81.8) - rs =1
P = 0.001








Ciprofloxacin 0 1/ 135 (0.7) - 0 0 0 1/135 (0.7) 0 0 0 0 - -
aTS, typhoidal salmonellae; bNTS, non-typhoidal salmonellae; crs, Spearman’s Correlaltion Coefficient, measures the overall significant increase or decrease in antibiotic resistance level over the 4-year period;
dP,
P-values at <0.05 are significant.













Figure 2 Incidence of Salmonella bactereamia per age distribution. Generated with Locally Weighted Scatterplot Smoothing (LOESS)
Tricube kernel smooth fit line with 50% of points to fit. The results show similarities in the incidence of TS and NTS with age. Overall, TS and NTS
increased with age and were highest in children below 5 years, but declined gradually over ages 5 through 32, remaining fairly constant among
the over 33 to 72-year-olds.
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sumptively diagnosed with sepsis (OR, 1.92; 95% CI, 0.94-
3.96; P-value, 0.072) or enteric fever (OR, 3.79; 95% CI,
1.18-12.09; P-value, 0.021). The MDR salmonellae were
more often recovered from patients presumptively diag-
nosed with enteric fever (OR, 3.99; 95% CI, 1.05-15.05;
P-value, 0.029). Non-MDRs were more frequently ob-
served among patients suspected of sepsis (n = 39/64,
60.9% versus n = 23/67, 34.3%; P-vaue, 0.002). Table 4
shows risk factors from multivariate analysis for
Salmonella BSI infection with typhoidal strains com-
pared to non-typhoidal isolates and with MDRs com-
pared to non-MDRs. In the end, among patients with
Salmonella BSI, those < 1 year old had reduced risk of
non-typhoidal infections [Odds ratio, 0.51; 95% confi-
dence interval (95% CI), 0.16-0.92, P-value 0.021]. Simi-
larly, patients with cefuroxime resistant strans were at
increased risk of having MDR Salmonella BSI (OR,
8.97; 95% CI, 3.62-24.15; P-value, 0.001).
Discussion
When poor public health prevails in low socio-
economic settings, it is natural to speculate that it will
have an impact on the health status of the people. This
may manifest itself as an increase in the incidence of
diseases, including Salmonella infections. Over the last
decade, several studies have demonstrated the clinical
significance of salmonellae causing infections in hospi-
tals. Despite this rise, there are very few reports from
West Africa, and Ghana in particular, on the occur-
rence of Salmonella infections.
To our knowledge this is the first study conducted in
Ghana across children and adult populations to docu-
ment the prevalence, circulating serotypes, antimicrobialresistance patterns, and seasonal variations in disease in-
cidence, as well as predisposing factors for blood stream
infections with salmonellae. Our study reveals an overall
low prevalence (6.5%) of Salmonella bactereamia among
patients in KBTH from January 2010 through December
2013. Approximately 64% (n = 115/181) of the isolates
were non-typhoidal Salmonella. Our finding of salmon-
ellae in KBTH is lower compared with that documented
elsewhere in Ghana (50%) [18], but higher than those
reported in other salmonellae-affected institutions in
India (0.69%) [10], and Tanzania (4.7%) [8]. The Korle-
bu Teaching Hospital from which these isolates were
recovered serves as a referral centre for primary and
secondary health care facilities mostly from the Southern
sector of Ghana. Thus most of these patients are likely
to have been treated with prior antibiotics which is likely
to reduce the culture yields.
There was a significant (P = 0.0002) prevalence of NTS
(4.1%) compared to TS (2.4%) over the study period.
The predominance of NTS over TS could be explained
in part by the preponderance of children in our study
population (86.8%, n = 151/174). In 2002, the estimated
prevalence of TS (27.6%) predominated over that of
NTS (40.7%) in patients with bacterial bloodstream
infections in rural hospitals in Ghana [18]. The figures
were lower (NTS, 18.8%; TS, 31.3%) 7 years later in the
same study, but still higher for TS contrary to the results
described in this study. In our study most patients were
children, while patients who had their diagnostic sam-
ples collected in the previous rural study were primarily
adults with a reported interquartile range of 26 years.
Using comparable methodology, our finding is much
closer to the 59% NTS and 25% TS previously reported
among bacteraemia children in this institution [19]. In a
Table 3 Baseline characteristics of patients














Male gender 98 34 64 0.85 (0.46-1.55) 0.590 50 48 1.74 (0.96-1.17) 0.065
Age (±SD)c 10.3 ± 2.5 9.0 ± 3.79 1.02 (0.82-1.76) 0.051 9.1 ±
1.8
9.3 ± 2.1 0.93 (0.81-1.65) 0.295
Aged
0-1 49 11 38 0.39 (0.18-0.84) 0.014 23 26 1.19 (0.61-2.31) 0.610
1-5 44 17 27 1.11 (0.55-2.25) 0.741 19 25 0.96 (0.48-1.92) 0.920
6-13 58 28 30 2.07 (1.08-3.96) 0.026 31 27 1.80 (0.95-3.41) 0.070
>13 23 8 15 0.90 (0.36-2.26) 0.823 7 16 0.51 (0.20-1.32) 0.162
Month of infectione
Jan-Mar 27 10 17 1.02 (0.44-2.40) 1.0 21 6 5.48 (2.09-14.36) 0.001
April-June 62 21 41 0.84 (0.44-1.60) 0.603 31 31 1.38 (0.74-2.55) 0.305
July-sept 47 17 30 0.98 (0.49-1.96) 1.0 21 26 0.99 (0.51-1.94) 1.0
Oct-Dec 45 18 27 1.22 (0.61-2.44) 0.571 13 32 0.41 (0.19-0.84) 0.013
Year of infection
2010 37 23 14 3.85 (1.82-8.20) 0.001 21 6 5.48 (209–14.36) 0.001
2011 54 13 41 0.44 (0.22-0.91) 0.02 31 23 2.07 (1.08-3.96) 0.025
2012 62 26 36 1.42 (0.75-2.68) 0.269 22 40 0.55 (0.29-1.05) 0.070
2013 28 13 15 1.63 (0.72-3.69) 0.233 7 21 0.35 (0.14-0.88) 0.02
Sickle cell diseasef 27 6 21 0.45 (0.17-1.19) 0.104 16 11 1.51 (0.64-3.56) 0.342
Physicians’
diagnosisf
Sepsis 62 27 35 1.92 (0.94-3.96) 0.072 23 39 0.33 (0.17-0.68) 0.002
Enteric fever 14 9 5 3.79 (1.18-12.09) *0.022 11 3 3.99 (1.05-15.05) 0.029
PUO 20 5 15 0.55 (0.18-1.63) 0.281 7 13 0.46 (0.17-1.23) 0.116
BEMP 13 3 10 0.51 (0.12-1.95) *0.378 5 8 0.56 (0.17-1.83) 0.33
Undiagnosed 71 21 50 0.56 (0.27-1.16) 0.118 35 36 0.85 (0.42-1.69) 0.646
Patient locationg
Child health 85 29 56 1.23 (0.56-2.71) 0.596 42 43 1.06 (0.52-2.22) 0.862
Medical 14 7 7 2.28 (0.75-7.00) *0.225 4 10 0.39 (0.11-1.28) 0.108
NICU 2 0 2 - - 0 2 - -
Surgical 2 0 2 - - 1 1 - -
PML 25 5 20 0.44 (0.15-1.26) 0.122 13 12 1.17 (0.49-2.80) 0.729
KBTH patientsh 102 36 66 0.76 (0.41-1.45) 0.416 47 55 0.59 (0.24-1.38) 0.223
Crx resistant
salmonellaei
32 11 21 0.89 (0.40-1.99) 0.79 27 5 8.35 (3.02-23.05) 0.001
Typhoidal
salmonella
66 - - - - 22 44 0.47 (0.25-0.89) 0.02
aCI, confidence interval; bBSI, blood stream infections; MDR, multidrg resistant strains; cSD, standard deviation; dRecorded for 64 TS and 110 NTS, and 75 MDR and
96 non-MDRs; eJan-Mar, January to March; Sep,september; Oct-Dec, October to December; fRecorded for 47 TS and 85 NTS, and 67 MDRs and 64 non-MDRs; PUO,
pyrexia of unknown origin; BEMP, bone infections, endocarditis, meningitis, pneumonia; gRecorded for 42 TS and 87 NTS, and 63 MDRs and 66 non-MDRs; NICU,
neonatal intensive care unit; PML, Princess-Marie Louis Children hospital; hKBTH, Korle-Bu Teaching Hospital, recorded for 42 TS and 87 NTS, and 63 MDRs and 66
non-MDRs; iCrx, cefuroxime, tested for 63 TS and 104 NTS, and 80 MDRs and 87 non-MDRs.
*P-vaue with Fisher’s exact test.
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Table 4 Risk factors for Salmonella bactreamia
Risk factor Level Odds ratio (95% CI) P-value
TS versus NTS bactereamia





Yes/No 8.97 (3.62-24.15) 0.001
TS, typhoidal Salmonella; NTS,non-typhoidal salmonella; MDRs, multidrug resistant
strains; Crx, cefuroxime; CI, confidence interval, BSI, blood stream infections.
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1,456 hospitalized children <15 years of age, the preva-
lence of TS, driven largely by S. Typhi, was 2.4% [20].
We cannot directly compare our figures with those ob-
served in that study because they did not assess NTS;
nevertheless, they seem to provide a similar qualitative
picture, in that the incidence of typhoidal fever is low in
children. Elsewhere in Africa, NTS has been shown to
be a prominent cause of blood stream infections in chil-
dren [7,21-23]. The interrelationship between severe
malaria, NTS, and HIV infection has been described
[24]. However, a much more consistent association has
been suggested between bactereamia due to NTS and se-
vere malaria [24,25]. In this study, we are unable to de-
termine the proportion of patients with HIV. But given
that children in Ghana are prone to develop malaria due
to the endemicity of the disease in this region, our find-
ing is perhaps be more explained by the association of
malaria with NTS.
Our study shows that TS and NTS bactereamia increased
with age and were highest in children below 5 years, but
declined gradually after the age of five years. This is corrob-
orated by other studies in Ghana [20]. The high prevalence
of Salmonella bloodstream infections in children under five
could be explained by the relative poor hygiene observed
by children within this group. We also observed that chil-
dren under 1 year were less likely to be infected with TS
and were less often infected with MDR strains; this is at
variance with another study in Ghana which showed that
the frequency of TS was low in children <2 years [20].
Peak isolation of Salmonella bloodstream infections
occurred between the periods of March and November.
This period marks the rainy season in Ghana [26], a
time when floods occur leading to contamination of
water bodies and an increase in the risk of developing
Salmonella infections. Similar associations have been
found in India [10] and Malawi [23] where the increase
in incidence of invasive Salmonella infections has been
associated with the rainy season.
Overall resistance of NTS and TS to ampicillin, tetra-
cycline and chloramphenicol was over 70%. Such high
resistance rates of Ghanaian salmonellae for ampicillin,
chloramphenicol and tetracycline have been recentlydescribed by Marks et al. [27]. There are other reports in
Ghana where high resistance of salmonellae to these agents
have been documented [5,18,20]. High resistance of
salmonellae to antimicrobial agents have also been docu-
mented elsewhere in subsaharan Africa [23,28,27]. In this
current study, resistance of NTS and TS to ciprofloxacin
and cefotaxime (recommended agents for treatment in
Ghana) [29] was very low compared to reports from India
where high resistance of about 13% to ciprofloxacin have
been documented [30]. The low resistance ciprofloxacin
and cefotaxime in Ghana have been coroborrated by others
[18,20,31]. The relatively recent introduction of these
agents as treatment options for invasive Salmonellosis may
have contributed to such low resistance. Morover, resist-
ance to these agents on the African continent is not wide-
spread but is said to be an emerging problem [27].
There are some potential limitations of this study that
should be discussed briefly. Blood stream infections from
Korle-Bu were identified as including TS and NTS which
constituted 6.5% of blood culture positive isolates. Whereas
this may reflect the relative incidence of organisms in a
Ghanaian tertiary care setting biased by its referral policies,
we were unable to determine if these were nosocomial in-
cidents or community acquired infections because of insuf-
ficient data on inpatient and outpatient status. Another
issue worth mentioning is the unavailability of data on
nalidixic acid screening for the detection of reduced
susceptibility of fluoroquinolone. To test for in vivo fluoro-
quinolone resistance, in vitro nalidixic acid is more appro-
priate. Quinolone-therapy will fail in spite of apparent
ciprofloxacin sensitivity if first resistance mutations have
occurred leading to in-vitro nalidixic acid resistance. Note
also that by being retrospective, some patients had been
stratified with predetermined definitions to which we were
unable to fully assess clinical history for correlations that
might contribute to the risk of TS or NTS infections. Pa-
tient clinical outcome data would have been very helpful in
the contextual interpretation of the multi-drug resistant
strain infections. Despite these shortcomings, our findings
offer baseline information needed to create the awareness
of salmonellae blood stream infections in Ghanaian hospi-
tals, and also the need for surveillance and control.
Conclusions
In conclusion, we report a 6.5% prevalence of Salmonella
bacteraemia at the Korle-Bu Teaching Hospital; with a pre-
ponderance of NTS over TS. Children under five bear the
brunt of the disease. Resistance to ciprofloxacin and cefo-
taxime, the recommended antimicrobial agents for treat-
ment remains low; although multi drug resistance to other
agents is high. In Ghana where Salmonella infections are
endemic, it is important to maintain surveillance of the dis-
ease to allow for appropriate and timely interventions when
required.
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